OncoSil Medical Limited (ASX:OSL)
Australia · Delayed Price · Currency is AUD 0.6500
-0.0050 (-0.76%)
Feb 26, 2026, 3:47 PM AEST
OncoSil Medical Market Cap
OncoSil Medical has a market cap or net worth of 15.47 million as of February 26, 2026. Its market cap has decreased by -51.93% in one year.
Market Cap
15.47M
Enterprise Value
12.66M
Revenue
3.72M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.65
Market Cap Chart
Since August 15, 2005, OncoSil Medical's market cap has increased from 7.29M to 15.47M, an increase of 112.04%. That is a compound annual growth rate of 3.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 15.47M | -15.59% |
| Dec 31, 2025 | 18.33M | -33.55% |
| Dec 31, 2024 | 27.58M | 55.21% |
| Dec 28, 2023 | 17.77M | -60.28% |
| Dec 30, 2022 | 44.74M | 25.48% |
| Dec 31, 2021 | 35.65M | -63.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Micro-X | 51.55M |
| Nova Eye Medical | 48.42M |
| CleanSpace Holdings | 44.68M |
| HeraMED | 40.09M |
| CurveBeam AI | 33.44M |
| ImpediMed | 32.62M |
| Atomo Diagnostics | 29.98M |
| Control Bionics | 23.00M |